Maximus MMS Concentration Risk %

Segments

Program Operations49.4%-2.6%

Clinical Services40.6%+9.7%

Technology Solutions6.5%—

Employment & Other4.6%-20.7%

Outside the US55%+10.0%

Revenue$1.3B-4.1%

Gross profit$342.3M+1.0%

Operating income$148.5M-2.9%

Net income$98.1M+1.5%

EPS (diluted)$1.80+6.5%

Cash & equivalents$157.5M+45.7%

Total debt$1.6B+0.5%

Total equity$1.7B+1.8%

Total assets$4.2B+0.9%

Operating cash flow-$244.4M-206%

CapEx$10.5M-38.9%

Free cash flow-$250.7M-143%

Market cap$2.94B-9.4%

Enterprise value$4.41B-7.5%

P/E7.9×-2.9×

P/S0.6×0.0×

Gross margin25.5%+1.8pp

Operating margin11%+1.8pp

Net margin7%+1.5pp

FCF margin4.1%-1.5pp

Return on equity22.2%+4.8pp

Debt / equity1×0.0×

Current ratio2.2×+0.4×